MARKET

CPHI

CPHI

CHINA PHARMA
AMEX

Real-time Quotes | Nasdaq Last Sale

0.8464
+0.0234
+2.84%
After Hours: 0.8400 -0.0064 -0.76% 17:11 04/13 EDT
OPEN
0.8990
PREV CLOSE
0.8230
HIGH
0.8990
LOW
0.8230
VOLUME
503.64K
TURNOVER
--
52 WEEK HIGH
1.630
52 WEEK LOW
0.3200
MARKET CAP
38.58M
P/E (TTM)
-12.8828
1D
5D
1M
3M
1Y
5Y
CAN, GNUS, NOVN and SEAC among midday movers
Gainers: VirTra (VTSI) +83%.Color Star Technology (CSCW) +39%.Performant Financial (PFMT) +36%.VivoPower International (VVPR) +32%.Moxian (MOXC) +26%.Mannatech (MTEX) +23%.Novan (NOVN) +21%.Canaan (CAN) +20%.Lizhi (LIZI) +17%.17 Education & Technology (YQ)...
Seekingalpha · 03/30 16:43
Novan, ShockWave Medical leads healthcare gainers; Wave Life Sciences, Trxade among major losers
Gainers: Novan (NOVN) +17%, ShockWave Medical (SWAV) +17%, Orphazyme (ORPH) +13%, Moleculin Biotech (MBRX) +14%, Annovis Bio (ANVS) +8%.Losers: Wave Life Sciences (WVE) -30%, Trxade (MEDS) -27%, Universe Pharmaceuticals (UPC) -23%, China Pharma (CPHI) -22%...
Seekingalpha · 03/30 15:00
Gold Fields, Danimer Scientific among premarket losers' pack
AeroCentury (ACY) -46% after filing petition for Chapter 11Wave Life Sciences (WVE) -27% on setback for Huntington’s disease trial (updated).Trxade Group (MEDS) -21% on Q4 earnings release.Vinco Ventures (BBIG) -16% on providing update to ZASH Global Media...
Seekingalpha · 03/30 12:42
Mid-Afternoon Market Update: Dow Rises 50 Points; Orphazyme Shares Plunge
Toward the end of trading Monday, the Dow traded up 0.16% to 33,123 while the NASDAQ fell 0.68% to 13,050.03. The S&P also fell, dropping 0.13% to 3,969.25.
Benzinga · 03/29 18:34
Mid-Day Market Update: Gold Drops Over 1%; Humanigen Shares Spike Higher
Midway through trading Monday, the Dow traded down 0.40% to 32,939.74 while the NASDAQ fell 1.16% to 12,985.73. The S&P also fell, dropping 0.72% to 3,946.07.
Benzinga · 03/29 16:10
Thinking about buying stock in China Pharma, Naked Brand, Rocket Companies, AMC Entertainment, or Cyanotech Corp?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CPHI, NAKD, RKT, AMC, and CYAN.
PR Newswire - PRF · 03/29 14:53
China Pharma reports FY results
China Pharma (CPHI): FY GAAP EPS of -$0.07.Revenue of $10.87M (-0.5% Y/Y)Press Release
Seekingalpha · 03/26 21:08
BRIEF-China Pharma Holdings, Inc. Reports Fiscal Year 2020 Financial Results
reuters.com · 03/26 21:06
More
Forecast
No Data
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CPHI. Analyze the recent business situations of CHINA PHARMA through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+1.86%
Pharmaceuticals & Medical Research
+0.68%
Key Executives
Chairman/President/Chief Executive Officer/Chief Financial Officer/Director
Zhilin Li
Director
Heung Tsui
Independent Director
Gene Bennett
Independent Director
Baowen Dong
Independent Director
Yingwen Zhang
No Data
About CPHI
China Pharma Holdings, Inc. is a holding company. The Company conducts its production, marketing, finance, development and administrative activities through its subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson) in the People's Republic of China (PRC). It is engaged in the development, manufacture and marketing of pharmaceutical products for human use in connection with various diseases and medical conditions in the PRC. It manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, oral solutions and granules. Its pharmaceutical products are sold on a prescription basis and are approved by the China Food and Drug Administration (the CFDA). The Company manufactured over 20 pharmaceutical products for various diseases and medical indications. It offers products for Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases and Others.

Webull offers kinds of China Pharma Holdings, Inc. stock information, including AMEX:CPHI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CPHI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CPHI stock methods without spending real money on the virtual paper trading platform.